Changes in desmin expression in patients with cardiac diastolic dysfunction and preserved or reduced ejection fraction

Advances in Medical Sciences

Volumn 60, Issue 1, 2015, Pages 148-155

  Pawlak, Agnieszka ^a   Gil, Robert Julian ^a,b   Nasierowska Guttmejer, Anna Maria ^c   Kasprzak, Jarosław D ^d  

^a CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERIOR   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c Central Clinical Hospital of Ministry of Internal Affairs   (Poland)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Desmin; Diastolic dysfunction; NT pro BNP; Proteins; Ventricular remodeling

Indexed keywords

DESMIN; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; ARTICLE; CARDIAC PATIENT; CONGESTIVE CARDIOMYOPATHY; CYTOSKELETON; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT ATRIUM PRESSURE; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART MUSCLE RELAXATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; NEW YORK HEART ASSOCIATION CLASS; PROTEIN EXPRESSION; REAL TIME ULTRASOUND SCANNER; CARDIOMYOPATHY; HEART VENTRICLE REMODELING; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; CARDIOMYOPATHIES; DESMIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; VENTRICULAR REMODELING;

EID: 84927775642     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.1016/j.advms.2015.01.009     Document Type: Article

References (30)

1. Redfield MM, Jacobsen SJ, Burnett Jr JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.
2. Fischer M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, Holmer S, et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003;24:320-8.
3. Borbély A, Papp Z, Edes I, Paulus WJ. Molecular determinants of heart failure with normal left ventricular ejection fraction. Pharmacol Rep. 2009;61(1): 139-45.
4. Pawlak A, Gil RJ, Kulawik T, Pronicki M, Karkuciń ska-Więckowska A, Szymańska-Dębiń ska T, et al. Type of desmin expression in cardiomyocytes-a good marker of heart failure development in idiopathic dilated cardiomyopathy. J Intern Med 2012;272:287-97.
5. Capetanaki Y. Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. Trends Cardiovasc Med 2002;12:339-48.
6. Milner DJ, Taffet GE, Wang X, Pham T, Tamura T, Hartley C, et al. The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. J Mol Cell Cardiol 1999;31:2063-76.
7. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991;83:504-14.
8. Milner DJ1, Weitzer G, Tran D, Bradley A, Capetanaki Y. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol. 1996;134(5):1255-70.
9. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
10. Garcia MJ, Ares MA, Asher C, Rodriguez L, Vandervoort P, Thomas JD. An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure. J Am Coll Cardiol 1997;29: 448-54.
11. Oh JK, Seward JB, Tajik AJ. The echo manual. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2006.
12. Di Somma S, Marotta M, Salvatore G, Cudemo G, Cuda G, De Vivo F, et al. Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans. Heart 2000;84:659-67.
13. Di Somma S, Di Benedetto MP, Salvatore G, Agozzino L, Ferranti F, Esposito S, et al. Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure. Eur J Heart Fail 2004;6:389-98.
14. Pawlak A, Gil RJ, Walczak E, Seweryniak P. Desmin expression in human cardiomyocytes and selected clinical and echocardiographic parameters in patients with chronic heart failure. Kardiol Pol 2009;67:955-61.
15. Monreal G, Nicholson LM, Han B, Joshi MS, Phillips AB, Wold LE, et al. Cytoskeletal remodeling of desmin is a more accurate measure of cardiac dysfunction than fibrosis or myocyte hypertrophy. Life Sci 2008;83:786-94.
16. Paulin D, Li Z. Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. Exp Cell Res 2004;301:1-7.
17. Duchen MR. Mitochondria and calcium: from cell signalling to cell death. J Physiol 2000;529:57-68.
18. Rizzuto R, Bernardi P, Pozzan T. Mitochondria as all-round players of the calcium game. J Physiol 2000;529:37-47.
19. Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol 2000;150:1283-98.
20. Dai DF, Chen T, Szeto H, Nieves-Cintrón M, Kutyavin V, Santana LF, et al. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardio-myopathy. J Am Coll Cardiol 2011;58:73-82.
21. Hein S, Kostin S, Heling A, Maeno Y, Schaper J. The role of the cytoskeleton in heart failure. Cardiovasc Res 2000;45:273-8 [review].
22. Heling A, Zimmermann R, Kostin S, Maeno Y, Hein S, Devaux B, et al. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 2000;86:846-53.
23. Mavroidis M, Capetanaki Y. Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy. Am J Pathol 2002;160:943-52.
24. Petrie MC, Hogg K, Caruana L, McMurray JJ. Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction. Heart 2004;90: 511-7.
25. Aeschbacher BC, Hutter D, Fuhrer J, Weidmann P, Delacrétaz E, Allemann Y. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens 2001;14:106-13.
26. Spencer KT, Lang RM, Kirkpatrick JN, Mor-Avi V. Assessment of global and regional left ventricular diastolic function in hypertensive heart disease using automated border detection techniques. Echocardiography 2003;20:673-81.
27. Thornell L, Carlsson L, Li Z, Mericskay M, Paulin D. Null mutation in the desmin gene gives rise to a cardiomyopathy. J Mol Cell Cardiol 1997;29:2107-24.
28. Tanaka M, Hiroe M, Nishikawa T, Sato T, Marumo F. Cellular localization and structural characterization of natriuretic peptide-expressing ventricular myo-cytes from patients with dilated cardiomyopathy. J Histochem Cytochem 1994;42:1207-14.
29. Henein M, Lindqvist P, Francis D, Mö rner S, Waldenström A, Tissue Kazzam E. Doppler analysis of age-dependency in diastolic ventricular behaviour and filling: a cross-sectional study of healthy hearts (the Umeå General Population Heart Study). Eur Heart J 2002;23:162-71.
30. Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, et al. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail 2008;10:252-9.